Related Experiment Video
Updated: Aug 16, 2025

Measuring 3D In-vivo Shoulder Kinematics using Biplanar Videoradiography
Published on: March 12, 2021
Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies
Alyssa Basdavanos1, Mathew S Maurer2, Lauren Ives1
1Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
Insights
Transthyretin cardiac amyloidosis (ATTR-CA) patients show higher rates of shoulder pathologies than other cardiac amyloidosis types. Early orthopedic manifestations may aid in earlier ATTR-CA diagnosis and treatment.
Area of Science:
- Cardiology
- Orthopedics
- Genetics
Background:
- Transthyretin cardiac amyloidosis (ATTR-CA) is a restrictive cardiomyopathy.
- ATTR-CA is linked to orthopedic issues preceding cardiac symptoms.
- Prevalence of shoulder pathologies in cardiac amyloidosis (CA) is understudied.
Purpose of the Study:
- To investigate the prevalence of shoulder pathologies in patients with CA.
- To compare orthopedic manifestations between ATTR-CA and light-chain CA (AL-CA).
- To assess if orthopedic issues can aid in early CA identification.
Main Methods:
- Single-center, retrospective, case-control study.
- Analyzed 1,310 patients with CA (830 ATTR-CA, 480 AL-CA).
- Compared CA patients to age-matched general population data for arthroplasty odds.
Main Results:
- ATTR-CA patients had significantly more shoulder pathologies and orthopedic manifestations than AL-CA patients (p <0.001).
- Patients aged 60+ with ATTR-CA had 6.05x higher odds of shoulder arthroplasty vs. controls.
- Patients aged 60+ with AL-CA had 1.63x higher odds of shoulder arthroplasty vs. controls.
Conclusions:
- Shoulder and other orthopedic pathologies are common in ATTR-CA.
- These findings may facilitate earlier identification of CA patients.
- Earlier diagnosis can lead to timely intervention and treatment.
Abstract:
Transthyretin cardiac amyloidosis (ATTR-CA) is a restrictive cardiomyopathy that has been associated with multiple orthopedic pathologies years before it manifests in the heart. There have been no studies on the prevalence of a wide range of shoulder pathologies in patients with cardiac amyloidosis (CA). Due to the preferential deposition of transthyretin in the soft tissues and joints, we predicted a greater prevalence of shoulder pathologies and other orthopedic manifestations in patients with ATTR-CA. This single-center, retrospective, case-control study, analyzed 1,310 patients with CA, 830 with ATTR-CA, and 480 with light-chain CA (AL-CA) from a dedicated CA REDcap database. Odds ratios comparing patients with CA to the age-matched published estimate of over 300 million patients in the general population were determined for shoulder, hip, and knee arthroplasty. Years between a patient's first shoulder pathology (i.e., shoulder arthroplasty) and the year of their diagnosis with CA were determined using data from patients with a known date of surgery. Overall, patients with ATTR-CA compared with patients with AL-CA presented more frequently with shoulder pathologies (p <0.001) and at least 1 orthopedic manifestation (p <0.001). The odds of patients with ATTR-CA and AL-CA aged 60 years or older who underwent shoulder arthroplasty was 6.05 times greater (95% confidence interval 4.26 to 8.60) and 1.63 times greater (95% confidence interval 0.67 to 3.94), respectively, compared with age-matched controls. Shoulder pathologies and concomitant orthopedic pathologies are common in patients with ATTR-CA and may help identify patients with CA earlier in their disease progression for earlier intervention and treatment.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations

